Guangdong Jiaying Pharmaceutical Co Ltd banner
G

Guangdong Jiaying Pharmaceutical Co Ltd
SZSE:002198

Watchlist Manager
Guangdong Jiaying Pharmaceutical Co Ltd
SZSE:002198
Watchlist
Price: 7.12 CNY 2.01% Market Closed
Market Cap: ¥3.6B

Relative Value

The Relative Value of one Guangdong Jiaying Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 7.12 CNY, Guangdong Jiaying Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Guangdong Jiaying Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Guangdong Jiaying Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Guangdong Jiaying Pharmaceutical Co Ltd
SZSE:002198
3.6B CNY 8.8 91.4 75.9 75.9
US
Eli Lilly and Co
NYSE:LLY
983.7B USD 15.1 47.7 32.1 34.2
US
Johnson & Johnson
NYSE:JNJ
585.8B USD 6.2 21.9 15.2 18.6
CH
Roche Holding AG
SIX:ROG
286.9B CHF 4.7 30.6 12.9 15
UK
AstraZeneca PLC
LSE:AZN
233.3B GBP 5.4 31.2 17.2 24.2
CH
Novartis AG
SIX:NOVN
241.3B CHF 5.5 22.2 13.7 17.6
US
Merck & Co Inc
NYSE:MRK
302B USD 4.6 16.5 10.3 12.1
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.7 11.4
US
Pfizer Inc
NYSE:PFE
156.8B USD 2.5 20.2 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
123.7B USD 2.6 17.5 6.8 8.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
G
Guangdong Jiaying Pharmaceutical Co Ltd
SZSE:002198
Average EV/EBITDA: 48.6
75.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
32.1
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.2
2%
7.6
CH
Roche Holding AG
SIX:ROG
12.9
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.2
11%
1.6
CH
Novartis AG
SIX:NOVN
13.7
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.3
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.7
7%
1.4
US
Pfizer Inc
NYSE:PFE
7.5
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
6.8
-13%
N/A